Realizing individualized cancer treatment through patient genome sequencing

Recent Publications

Okamoto, K., Ohishi, T., Kuroiwa, M., Iemura, S., Natsume, T. and Seimiya, H.
MERIT40-dependent recruitment of tankyrase to damaged DNA and its implication for cell sensitivity to DNA-damaging anticancer drugs.
Oncotarget, 9, 35844-35855 (2018)
Yonekura, R., Osako, T., Iwase, T., Ogiya, A., Ueno, T., Kitagawa, M., Ohno, S. and Akiyama, F.
Prognostic impact and possible pathogenesis of lymph node metastasis in ductal carcinoma in situ of the breast.
Breast Cancer Res. Treat., in press (2018)
Hatta, T., Iemura, S., Ohishi, T., nakayama, H., Seimiya, H., Iizuka, K., Takeda, J., Natsume, T. and Horikawa, Y.
Calpain-10 regulates actin dynamics by proteolysis of microtubule-associated protein 1B.
Sci. Rep., 8, 16756 (2018)
Yamamoto, T., Sakamoto, C., Tachiwana, H., Kumabe, M., Matsui, T., Yamashita, T., Shinagawa, M., Ochiai, K., Saitoh, N. and Nakao, M.
Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.
Sci. Rep., 8, 15202 (2018)
Fujiwara, C., Muramatsu, Y., Nishii, M., Tokunaka, K., Tahara, H., ueno, M., Yamori, T., Sugimoto, Y. and Seimiya, H.
Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells.
Sci. Rep., in press (2018)